A direct comparison of efficacy between desloratadine and rupatadine in seasonal allergic rhinoconjunctivitis: a randomized, double-blind, placebo-controlled study

References

• BauchauVDurhamSRPrevalence and rate of diagnosis of allergic rhinitis in EuropeEur Respir J200424575876415516669
   PubMed Web of Science ®Google Scholar
• BachertCvan CauwenbergePOlbrechtJvan SchoorJPrevalence, classification and perception of allergic and nonallergic rhinitis in BelgiumAllergy200661669369816677237
   PubMed Web of Science ®Google Scholar
• BousquetJKhaltaevNCruzAAWorld Health OrganizationGA(2)LEN, AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)Allergy200863Suppl 86816018331513
   PubMed Web of Science ®Google Scholar
• SchatzMA survey of the burden of allergic rhinitis in the USAAllergy200762Suppl 8591617927673
   PubMed Web of Science ®Google Scholar
• MullolJA survey of the burden of allergic rhinitis in SpainJ Invest Allergol Clin Immunol20091912734
   Web of Science ®Google Scholar
• HoreIGeorgalasCScaddingGOral antihistamines for the symptom of nasal obstruction in persistent allergic rhinits – a systematic review of randomized controlled trialsClin Exp Allergy200535220721215725193
   PubMed Web of Science ®Google Scholar
• MerlosMGiralMBalsaDRupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF)J Pharmacol Exp Ther199728011141218996188
   PubMed Web of Science ®Google Scholar
• QueraltMBrazisPMerlosMPuigdemontAInhibitory effects of rupatadine on mast cell histamine release and skin wheal development induced by Ascaris suum in hypersensitive dogsDrug Dev Res1998444955
   Web of Science ®Google Scholar
• PiwinskiJJWongJKGreenMJDual antagonists of platelet activating factor and histamine. Identification of structural requirements for dual activity of N-Acyl-4-(5,6-dihydro-11H-benzo[5,6] cyclohepta-[1.2-b]pyridin-11-ylidene)piperidinesJ Med Chem19913414574611671420
   PubMed Web of Science ®Google Scholar
• AlfaroVRole of histamine and platelet-activating factor in allergic rhinitsJ Phisiol Biochem2004602101111
   Web of Science ®Google Scholar
• MullolJBousquetJBachertCRupatadine in allergic rhinitis and chronic urticariaAllergy200863 Suppl 8752818339040
   PubMed Web of Science ®Google Scholar
• KeamSJPloskerGLRupatadine: a review of its use in the management of allergic disordersDrug2007673457474
   Web of Science ®Google Scholar
• European medecines AgencyICH Topic E 6 (R1) Guideline for Good Clinical Practice Available from: http://www.emea.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002874.pdfAccessed 3 Jan 2013
   Google Scholar
• SalmunLMLorberR24-hour efficacy of once-daily desloratadine therapy in patients with seasonal allergic rhinitis [ISRCTN32042139]BMC Fam Pract200231412162793
   PubMedGoogle Scholar
• BachertCKunaPSanquerFBilastine International Working GroupComparison of the efficacy and safety of bilastine 20 mg vs desloratadine 5 mg in seasonal allergic rhinitis patientsAllerg y2009641158165
   PubMed Web of Science ®Google Scholar
• SchenkelEJEffect of desloratadine on the control of morning symtoms in patients with seasonal and perennial allergic rhinitisAllergy Asthma Proc200627646547217176780
   PubMed Web of Science ®Google Scholar
• Van CauwenbergePJuniperEFComparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitisClin Exp Allergy200030689189910848909
   PubMed Web of Science ®Google Scholar
• GehaRSMeltzerEODesloratadine: A new, nonsedating, oral antihistamineJ Allergy Clin Immunol2001107475176211295678
   PubMed Web of Science ®Google Scholar
• CanonicaG WTarantiniFCompalatiEPenagosMEfficacy of desloratadine in the treatment of allergic rhinitis: a meta-analysis of randomized, double-blind, controlled trialsAllergy200762435936617362245
   PubMed Web of Science ®Google Scholar
• FumagalliFBaiardiniIPasqualiMAntihistamines: do they work? Further well-controlled trials involving larger samples are neededAllergy200459 Suppl 78747715245363
   PubMed Web of Science ®Google Scholar
• BousquetJBachertCCanonicaGWACCEPT-1 study groupEfficacy of desloratadine in intermittent allergic rhinitis: a GA(2)LEN studyAllerg y2009641015161523
   PubMed Web of Science ®Google Scholar
• BachertCvan CauwenbergePDesloratadine treatment for intermittent and persistent allergic rhinitis: a reviewClin Ther20072991795180218035184
   PubMed Web of Science ®Google Scholar
• FantinSMasperoJBisbalCInternational Rupatadine study groupA 12-week placebo-controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitisAllergy200863792493118588560
   PubMed Web of Science ®Google Scholar
• KeithPKLuciukGEffectiveness of desloratadine 5 mg once daily in patients with symptoms of seasonal allergic rhinitis: results of a Canadian multicenter, open-label trialClin Ther200729341942617577463
   PubMed Web of Science ®Google Scholar
• BachertCVirchowCJJrPlenkerADesloratadine in the treatment of seasonal allergic rhinitis: results of a large observational studyClin Drug Investig2002224352
   Web of Science ®Google Scholar
• GuadañoEMSerra-BatllesJMeseguerJRupatadine Study GroupRupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: a comparison studyAllergy200459776677115180765
   PubMed Web of Science ®Google Scholar
• Martinez-CóceraCDe MolinaMMartí-GuadañoESpanish Rupatadine Rhinitis Study GroupRupatadine 10 mg and cetirizine 10 mg in seasonal allergic rhinitis: a randomised, double-blind parallel studyJ Investig Allergol Clin Immunol20051512229
   Web of Science ®Google Scholar
• MullolJPositioning of antihistamines in the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelinesClinical and Experimental Allergy Reviews20121211726
   Google Scholar
• DonadoEIzquierdoIPérezINo cardiac effects of therapeutic and supratherapeutic doses of rupatadine: results from a ‘thorough QT/ QTc study’ performed according to ICH guidelinesBr J Clin Pharmacol201069440141020406224
   PubMed Web of Science ®Google Scholar
• European Medicines AgencyICH Topic E 14. The Clinical Evaluation of QT/Qtc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic DrugsLondon, UKICH Steering Committee2005 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientifc_guideline/2009/09/WC500002879.pdfAccessed Nov 2012
   Google Scholar